Aerovate Therapeutics, Inc. (AVTE)

Aerovate Therapeutics Market Cap

Aerovate Therapeutics has a market cap or net worth of $591.43 million as of May 17, 2024. Its market cap has increased by 12.76% in one year.

• Market Cap: 591.43M
• Enterprise Value: 492.87M
• 1-Year Change: 12.76%
• Ranking: #2860
• Category: Small-Cap
• Stock Price: $20.57

Market Cap Chart

Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has increased from $323.51M to $591.43M, an increase of 82.82%. That is a compound annual growth rate of 23.31%.

Market Cap History

Date	Market Cap	% Change
May 16, 2024	631.20M	4.28%
May 15, 2024	605.30M	8.98%
May 14, 2024	555.40M	0.73%
May 13, 2024	551.40M	-0.20%
May 10, 2024	552.50M	-8.02%
May 9, 2024	600.70M	2.47%
May 8, 2024	586.20M	2.93%
May 7, 2024	569.50M	-0.87%
May 6, 2024	574.50M	1.63%
May 3, 2024	565.30M	-2.23%
May 2, 2024	578.20M	-0.43%
May 1, 2024	580.70M	4.16%
Apr 30, 2024	557.50M	-2.64%
Apr 29, 2024	572.60M	-5.51%
Apr 26, 2024	606.00M	0.83%
Apr 25, 2024	601.00M	1.74%
Apr 24, 2024	590.70M	-8.70%
Apr 23, 2024	647.00M	4.74%
Apr 22, 2024	617.70M	0.54%
Apr 19, 2024	614.40M	2.09%
Apr 18, 2024	601.80M	-4.00%
Apr 17, 2024	626.90M	-4.74%
Apr 16, 2024	658.10M	-6.64%
Apr 15, 2024	704.90M	0.23%
Apr 12, 2024	703.30M	-6.13%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
SI-BONE	613.54M
Varex Imaging	611.86M
Valneva SE	605.68M
Cabaletta Bio	595.25M
Harrow Health	591.58M
GeneDx Holdings	591.14M
Calliditas Therapeutics AB (publ)	588.25M
PetIQ	584.95M